Publications

Subject/Therapeutic Area: Nervous system

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Systematic review of the burden of pediatric multiple sclerosis in North America and Europe.

Author: Krupp LB, Goble JA, Toledano H, Thompson M, Pervaiz N, Vieira MC

View

Subject/Therapeutic Area: Oncology

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Validation of the impact of treatment evolution in non-small cell lung cancer (NSCLC) model (ITEN): a discrete event patient simulation.

Author: Moldaver D, Hurry M, Tran D, Grima D

View

Subject/Therapeutic Area: Oncology

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Budget impact analysis of tisagenlecleucel for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma in England.

Author: Hollmann S, Painter C, Hogan A, Morten P, Goyert N, Vieira J, Slowley A, Jousseaume E, El Ouagari K, Zhang J, Jewitt K, Ma Q

View

Subject/Therapeutic Area: Other

Journal/Conference: ISPOR Europe, Barcelona, Spain (2018)

Budget impact analysis of a dual-layer stent retriever (DLSR) for the treatment of patients with acute ischemic stroke (AIS) in England.

Author: Ehm A, Crivera C, Qadeer R, Cameron HL

View

Subject/Therapeutic Area: Oncology

Journal/Conference: ISPOR 23rd Annual International Meeting Baltimore, MD, USA (2018)

Positive cancer drug recommendations by the pan-Canadian Oncology Drug Review are not without conditions placed on cost-effectiveness.

Author: Grima A, Whitney S, Samjoo I, Grima D

View

Copyright © 2018. All Rights Reserved. Cornerstone Research Group